At a glance
ClinicalIndex Comparison RecordN/ACompleted· 141 enrolled
Drug / intervention
whey protein isolate +3 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Impact of Protein and Alkali Supplementation on Skeletal Muscle in Older Adults
In Brief
A clinical study evaluating whey protein isolate, potassium bicarbonate (KHCO3), and 2 other interventions for Age-Related Sarcopenia and Muscle Loss. Completed, enrolled 141 participants across 1 site.
Detailed Summary
The central hypothesis is that higher protein intake and a neutralizing alkaline salt supplement will improve muscle performance and mass, compared to their respective placebos, in older men and postmenopausal women.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAge-Related Sarcopenia, Muscle Loss
CountriesUnited States
CollaboratorsNational Institute on Aging (NIA)
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedAug 2019
Enrollment StartJul 2021
Primary CompletionDec 2023
TodayJul 2026
First PostedAug 7, 2019
Enrollment StartJul 1, 2021
Primary CompletionDec 21, 2023
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 6.9 years ago
Interventions
whey protein isolatedietary
one 15-25 gm (based on body weight) protein packet three times a day with each meal
potassium bicarbonate (KHCO3)dietary
two 13.5 mmol capsules three times a day with each meal
microcrystalline celluloseother
identical placebo capsule
maltodextrin powderother
isocaloric placebo powder